SMTL ID : 6c4g.1

Plasmepsin V from Plasmodium vivax bound to a transition state mimetic (WEHI-601)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.39 Å
Oligo State
monomer
Ligands
1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x EQG: benzyl [(6S,7S,10S,13S,18Z)-18-amino-10-cyclohexyl-6-hydroxy-18-imino-7-(2-methylpropyl)-4,9,12-trioxo-1-phenyl-16-oxa-3,8,11,17-tetraazaoctadecan-13-yl]carbamate(Non-covalent)
2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nguyen, W. et al., Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2position of PEXEL peptidomimetics. Eur J Med Chem (2018)
Release Date
2018-06-13
Peptides
Aspartic protease PM5: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Aspartic protease PM5

Related Entries With Identical Sequence

4zl4.1 | 4zl4.2